Validation of a new immune checkpoint molecule as a target for cancer immunotherapy - UQ Researchers

Validation of a new immune checkpoint molecule as a target for cancer immunotherapy (2019–2020)

Grant type:: Tour de Cure
Funded by:: The Trustee for Tour De Cure Trust

The University of Queensland

Brisbane St Lucia, QLD 4072

+61 7 3365 1111

Other Campuses: UQ Gatton, UQ Herston

Maps and Directions

© 2024 The University of Queensland

A Member of

Privacy & Terms of use | Feedback

Authorised by: Director of OMC

ABN 63 942 912 684

CRICOS Provider No:00025B

Explore

Need Help?

Emergency

Ph. 3365 3333